2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$13.22+$0.20 (+1.51%)
Price as of Jul 14, 2026 4:10 AM EDT- $2.0BMarket Cap
- 8.95%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$13.22+$0.20 (+1.51%)
NTLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.02 | ||
Change | -$1.19 (-8.41%) | ||
Open | $13.76 | ||
High | $13.77 | ||
Low | $12.77 | ||
Previous Close | $14.21 | ||
Volume | 7,479,067 | ||
30-Day Average Volume | 6,428,198 | ||
1-Week Change | -27.02% | ||
1-Month Change | 7.51% | ||
1-Year Change | 8.95% | ||
3-Year Change | -71.56% | ||
5-Year Change | -90.92% | ||
Fundamentals | |||
Shares Outstanding | 139.7M | ||
Total Assets | $758.8M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $15.0M | ||
Net Income | -$96.2M | ||
Free Cash Flow | -$117.4M | ||
EBIT | -$96.2M | ||
EBITDA | -$94.0M | ||
Net Working Capital | $390.0M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 123 | ||
P/B | 3 | ||
P/E | -18 | ||
PEG | -9 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue